SCHEMBL6004654

SCHEMBL6004654

COc1ccc2cc(-c3ccc(F)cc3F)ccc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.57
AKR1C3 P42330 1/20 0.55
AKR1C2 P52895 1/20 0.55
HSD17B1 P14061 1/20 0.51
HSD17B2 P37059 1/20 0.51
AMY1A P0DUB6 1/20 0.49
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
CYP11B1 P15538 7/20 0.48
CYP11B2 P19099 7/20 0.48
CYP1A2 P05177 4/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2B6 P20813 1/20 0.46
PTGS2 P35354 1/20 0.46
TRPA1 O75762 1/20 0.45
CYP1A1 P04798 1/20 0.45
CYP1B1 Q16678 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5981063 0.91 GSTP1 (0.62) GSTP1AKR1C3AKR1C2HSD17B1HSD17B2
SCHEMBL6068558 0.86 CYP2C19 (0.55) AMY1ACYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL18963363 0.85 GSTP1 (0.56) GSTP1AKR1C3AKR1C2HSD17B1HSD17B2
SCHEMBL227029 0.84 CYP11B1 (0.55) GSTP1AKR1C3AKR1C2HSD17B1HSD17B2
SCHEMBL30979884 0.82 APP (0.51) AMY1ACYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL15588476 0.82 APP (0.51) AMY1ACYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL10014739 0.81 AKR1C3 (0.58) AKR1C3AKR1C2CYP1A2CYP3A4CYP2C9
SCHEMBL225282 0.81 CYP11B1 (0.58) GSTP1AKR1C3AKR1C2HSD17B1HSD17B2
SCHEMBL7695294 0.80 CYP1A2 (0.60) GSTP1HSD17B1HSD17B2CYP1A2TRPA1
SCHEMBL30979865 0.79 APP (0.46) AMY1ACYP2C19CYP1A1CYP1B1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1709021-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2006-10-11 EP disclosed
WO-2005073204-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2005-08-11 WO disclosed